Constant use of oral anticoagulants: implications in the control of their adequate levels;Uso crónico de anticoagulante oral implicaciones para el control de niveles adecuados

Arquivos Brasileiros de Cardiologia

Volumn 93, Issue 5, 2009, Pages

  Esmerio, Francieli Giachini ^a   Souza, Emiliane Nogueira ^a   Leiria, Tiago Luz ^a   Lunelli, Rosana ^a   Moraes, Maria Antonieta ^a  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Anticoagulants; Drug control; Drug utilization

Indexed keywords

PHENPROCOUMON; WARFARIN; ANTICOAGULANT AGENT;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNOWLEDGE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PERCEPTION; PROSTHETIC VALVE THROMBOSIS; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT INDICATION; ATTITUDE TO HEALTH; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; STATISTICS; VALVULAR HEART DISEASE;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART VALVE DISEASES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 76149119786     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009001100017     Document Type: Article

References (20)

1. Arnason T, Wells PS, Walraven C, Foster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res. 2006; 118 (2):253-62.
2. Sawicki PT. A structured teaching and self-management program for patients for receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA. 1999; 281 (2): 145-50.
3. Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguCheck TM S point-of-care monitor and a robust education program. Thromb Res. 2006; 118 (5): 587-93.
4. Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcome. 2004; 2: 22.
5. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation Guide to warfarin therapy. J Am Coll Cardiol. 2003; 41 (9): 1633-52.
6. Davis NJ, Billett HH, Cohen HW, ArnsAten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005; 39: 632-6.
7. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986; 24: 67-74.
8. Yasaka M, Naritomi H, Minematsu K. Ischemic stroke associate with brief cessation of warfarin. Thromb Res. 2006; 118 (2): 290-3.
9. Adherence to long-term therapies. Evidence for action. World Health Organization. Geneva: Word Health Organization, 2003. [acesso em 2007 Mar 2]. Disponível em: http://www.who.int/chp/knowledge/publications/ adherencereport/en;index.html
10. Bloom BS, Engelhart MD, Furst EJ, Hill WH, Krathwohl DR. Taxonomia de objetivos educacionais: domínio cognitivo. Porto Alegre: Globo, 1973.
11. Fredman MD. Oral anticoagulants: pharmacodynamics, clinical indications and adverse effects. J Clin Pharmacol. 1992; 32 (3): 196-209.
12. Fihn SD, Gadisseur AA, Pasterkamp E; van der Meer FJ, Breukink-Engbers WG, Geven-Boere LM, et al. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost. 2003; 90 (2): 260-6.
13. Kimmel SE, Chen Z, Price M, Parker CS, Metlay NW, Christie JD, et al. The influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med. 2007; 167: 229-35.
14. Nakkar N, Kaur R, John M. Outpatient oral anticoagulant management: an audit of 82 patients. J Assoc Physicians India. 2005; (53): 847-52.
15. Sawicki PT, Gläser B, Kleespies C, Stubbe J, Schimitz N, Kaiser T, et al. Self-management of oral anticoagulation: long-term results. J Intern Med. 2003; 254 (5): 515-6.
16. Leite SN, Vasconcellos MPC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Ciência Saúde Coletiva. 2003; 8 (3): 775-82.
17. Grinberg M. Entendo, aceito, faço: estratégia pró - adesão à anticoagulação oral. Arq Bras Cardiol. 2004; 82 (4): 309-12.
18. Yermiahu T, Arbelle JE, Shwartz D, Levy Y, Tractinsky N, Porath A. Quality assessment of oral anticoagulant treatment in Beer-Sheba district. Int J Qual Health Care. 2001; 13 (3): 209-13.
19. Duarte PS, Ciconelli RM. Instrumento para avaliação da qualidade de vida: genéricos e específicos. In: Diniz DP, Schor N. Guia de qualidade de vida. São Paulo: Manole, 2006. p.11-8.
20. Nakkar N, Kaur R. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution: a questionnaire survey. J Assoc Physicians India. 2004; (52): 868-72.